Teens aren't careful about hygiene while cookingNovember 12th, 2009 WASHINGTON - Teens are less likely to wash their hands while cooking and are more likely to cross-contaminate raw food than adults, says a new study. "While half of the adults we observed washed their hands after touching raw chicken, none of the adolescents did," said Casey Jacob, study co-author and food safety research assistant at Kansas State University (KSU).
Abbott Labs says it will pay $170M upfront for experimental chronic pain drug from PanGeneticsNovember 12th, 2009 more images
more imagesAbbott buys pain drug candidate for up to $190MNORTH CHICAGO, Ill. — Abbott Laboratories said Thursday it is buying a potential chronic pain drug from PanGenetics BV for as much as $190 million.
Bristol-Myers Squibb signs development deal for rheumatoid arthritis drug with Alder BiopharmaNovember 10th, 2009 more images
more imagesBristol-Myers signs development deal with AlderNEW YORK — Bristol-Myers Squibb Co. and Alder Biopharmaceuticals Inc.
Restless legs syndrome more prevalent in non-African-American womenNovember 3rd, 2009 WASHINGTON - Restless legs syndrome (RLS), a sleep disorder characterized by the strong urge to move the legs, is more prevalent in non-African-American women, a new study has found. Ammar Alkhazna, MD, University of Missouri, Kansas City, MO, and colleagues discovered that Caucasian women might suffer RLS up to four times more than African-American women.
Sleep disorder, inflammation linked to heightened pain in arthritis patientsOctober 29th, 2009 WASHINGTON - A new study has found that inflammation and sleep problems are associated with increased pain in rheumatoid arthritis (RA) patients. Researchers from the Division of Rheumatology and Pain Management Center of Brigham and Women's Hospital, and the Chronic Pain and Fatigue Center of the University of Michigan Medical School, claim that while inflammation is linked to heightened pain sensitivity at joint sites, increased sleep problems are associated with heightened pain sensitivity at both joint and non-joint sites.
How fish oils help fight arthritisOctober 29th, 2009 LONDON - Fish oils are known for their beneficial health effects, but how and why they produce anti-inflammatory effects remains uncertain. Now, British researchers claim to have uncovered a mechanism that explains why taking fish oils can help with conditions like rheumatoid arthritis.n the new study, the research team showed how the body converts an ingredient found in fish oils into another chemical called Resolvin D2 and how this chemical reduces the inflammation that leads to a variety of diseases.
Immune system-suppressing drugs 'raise bladder cancer risk'October 27th, 2009 WASHINGTON - In a recent study of possible triggers of cancer, scientists identified an increased risk to the bladders of patients taking drugs that suppress the immune system. The findings came from a population-based, case-control study in New Hampshire.
Moderate weight loss could trim risk of osteoarthritis in the kneeOctober 19th, 2009 WASHINGTON - Losing even a moderate amount of weight could help cut down the risk of developing osteoarthritis in the knees, according to a study. Data from an ongoing study by the Thurston Arthritis Research Center, University of North Carolina at Chapel Hill School of Medicine, revealed people who are overweight and shed just 5 percent of their weight were less likely to develop knee OA, a common joint disease affecting middle-aged and older people, compared to people who gain weight.
FDA rejects expanded use of rheumatoid arthritis drug RituxanOctober 17th, 2009 FDA nixes wider use of rheumatoid arthritis drugThe Food and Drug Administration has rejected an application to expand the use of rheumatoid arthritis treatment Rituxan for patients with earlier stages of the disease, biotech drug developers Genentech Inc. and Biogen Idec said Saturday.
Micrometer-sized capsules may put an end to regular drug dosingOctober 2nd, 2009 WASHINGTON - Experts at Queen Mary, University of London, have come up with micrometer-sized capsules that can safely deliver drugs inside living cells, and allow full courses of prescription drugs to be effectively "shrink-wrapped" and buried under the skin or inside the body. Writing about their innovation, they have revealed that the "micro shuttles" can be loaded with a specific dose of medication and be opened remotely.
Edible apple film wraps can protect meat, poultry products from foodborne pathogensSeptember 27th, 2009 WASHINGTON - A new study led by Indian-origin researcher has revealed that edible apple film wraps can protect meat and poultry products from foodborne pathogens. Researchers from the University of Arizona used arvacrol and cinnamaldehyde in apple-based films, which showed promise in offering protection against Salmonella enterica, Escherichia coli O157:H7 and Listeria monocytogenes.
ZymoGenetics says Atacicept did not meet goals for advancing directly to late-stage testingSeptember 10th, 2009 ZymoGenetics says RA drug misses advancement goalsSEATTLE — ZymoGenetics Inc. said Thursday that its drug candidate Atacicept did not meet goals that would have automatically advanced it to late-stage clinical testing as a treatment for rheumatoid arthritis.
Doctor: Mass. Gov. Patrick OK after hip replacement surgery for arthritis, pre-existing injurySeptember 1st, 2009 Gov. Patrick OK after hip replacement surgeryBOSTON — Massachusetts Gov. Deval (deh-VAHL') Patrick is resting comfortably after undergoing hip replacement surgery to alleviate pain from arthritis and an injury he sustained three decades ago.
Gene behind gum disease, osteoporosis, arthritis identifiedAugust 31st, 2009 WASHINGTON - An international team of researchers have identified a gene that is common in the development of gum disease, rheumatoid arthritis, and osteoporosis. Experts at Hospital for Special Surgery say that their findings about the gene, called interferon regulator factor-8 (IRF-8), may lead to new treatments in future.
New Cytotron treatment effective in treating cancer patients in BangaloreAugust 28th, 2009 BANGALORE - The new Cytotron treatment that includes use of radio frequency, high power non-ionizing, non-thermal electromagnetic waves instead of high frequency radiation has emerged as a popular therapy for cancer patients in Bangalore. Developed by Rajah Vijay Kumar of India in 1987, the Cytotron device helps in tissue regeneration, degeneration and repair for the purposes of treating several chronic or degenerative diseases such as cancer and arthritis.
